Versameb AG Alternatives & Competitors
12 companies similar to Versameb AG — The next generation of RNA therapeutics
Companies similar to Versameb AG
DEM Biopharma, Inc.
Novel Target for Solid Tumors
Cambridge, United States
Rgenta Therapeutics Inc.
We unlock the therapeutic potentials of highly disease-relevant targets undruggable by sma...
Woburn, United States
Skye Bioscience Inc.
Unlocking new therapeutic pathways for metabolic health
San Diego, United States
Ribometrix Inc.
Combining the proven power of small molecules with the promise of RNA targeting to create...
Durham, United States
Track all Versameb AG competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
ADC Therapeutics
Innovating Science. Inspiring Hope.
Lausanne, Switzerland
Arrakis Therapeutics
Arrakis is on a path to bring powerful new RNA-targeted small molecule (rSM) therapies to...
Waltham, United States
EOLO PHARMA
Cutting-Edge Pharmacological Treatment for Obesity
San Francisco, United Sta...
Laminar Pharma
Biopharmaceutical company performing discovery, rational design and initial clinical devel...
Spain
Parabilis Medicines
We are dedicated to creating extraordinary medicines for people affected by serious diseas...
Cambridge, United States
Yuanyin Bio
Pioneering the future of medicine with groundbreaking RNA technology to tackle unmet clini...
Oslo, Norway
Orna Therapeutics
Wholly Owned Subsidiary of Eli Lilly and Company
Watertown, United States
About Versameb AG
Versameb AG, founded in 2017 and based in Switzerland, is at the forefront of the biotechnology and pharmaceutical industries, focusing on RNA therapeutics. Their innovative approach centers on developing breakthrough RNA-based drugs that modulate protein expression with precision and target multiple therapeutic areas...
Development of RNA-based therapeutics, Research and innovation in genetic medicine, Collaboration with healthcare partners
Healthcare providers, Pharmaceutical companies, Medical researchers, Biotech investors
RNA Therapeutics, RNA-based Drugs, Protein Expression Modulation, Therapeutic Targets, VERSagile Technology, Functional RNA, Drug Discovery, Drug Development, Clinical Study, Stress Urinary Incontinence, Solid Tumors, Rare Diseases, Molecular Construct, Cellular Targeting
B2B, B2D
Licensing, Project Based, Service Fee
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Versameb AG and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Versameb AG on 20 Mar 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
